About 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors manufactured by Abbott were recalled in November, because they might give wrong readings.
New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.
Zydus Lifesciences announced its new offering companion diagnostics portfolio. The company will be launching Diasens and GlucoLive, next-generation Continuous Glucose Monitoring (CGM) devices that ...
Zydus Lifesciences has announced the launch of its companion diagnostics portfolio with the introduction of Diasens and ...
Glooko, Inc., a globally integrated digital healthcare company focused on helping healthcare systems solve the growing challenges of glycemic safety and diabetes management across care settings, today ...
Hosted on MSN
What to Know About Continuous Glucose Monitoring
Continuous glucose monitors (CGMs) give 24-hour real-time blood sugar readings. CGMs help with managing diabetes by reducing finger pricks and alerting users to low or high glucose levels. CGMs can be ...
Theranica, a neuromodulation therapeutics company advancing clinically validated, drug-free treatments for idiopathic pain conditions and setting a new standard of care in migraine with REN-based ...
Glooko has announced that the Glooko platform will integrate with the Roche Accu-Chek SmartGuide continuous glucose monitor (CGM) solution across select European countries, subject to local availabili ...
In patients with type 1 diabetes, use of continuous glucose monitoring (CGM) devices -- alone or with insulin pumps -- was associated with lower odds of developing diabetic retinopathy and ...
Continuous glucose monitoring (CGM) technology, while very early in its development, has been optimistically extolled in numerous editorial and technical reviews in the medical literature as “the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results